Latest News

 Filter by Provider

At its current pace, the software giant could spend it all before 2030. What might that do to earnings per share?

Starlink cash flows are helping SpaceX to invest aggressively elsewhere.

The stock market has followed a fairly predictable cycle when the Fed starts raising rates.

The warehouse club's underlying sales growth has slowed three months in a row. Will Wednesday's report snap the streak?

Splashy growth stocks are exciting. You don't invest for entertainment, though, particularly if you're new. Getting started on a firm footing allows you to be selectively aggressive in the future.

Galiano Gold (NYSEAMERICAN:GAU) outlined plans to lift gold production, expand reserves and increase cash flow as higher-grade ore reaches its processing plant and an existing gold-price hedge expires. During a company presentation, Matt, speaking for Galiano, said the company is targeting 2026 pro

Both semiconductor companies are poised to grow at an incredible pace due to the incredible demand for memory and custom AI processors.

Investors should get comfortable owning what has become a capital-intensive business.

There are blazing deals for some of the top healthcare stocks -- companies with proven track records and dividend yields as high as 6%.

Stocks might not be as expensive as they first appear.

Both trade under their peaks. What might carry each through the rest of the decade?

The company is the leader in a key growth market.

MercadoLibre is more focused on the future than the present.

Market cap is a quick way of understanding the total size and value of a company.

These stocks offer juicy yields and attractive risk-reward profiles.

PepsiCo and Hershey sell everyday brands that can belong in a buy-and-never-sell dividend portfolio.

If you're married or have been married, here's how to find out whether you qualify for spousal benefits.

Next year's Social Security increase could exceed the 3.5% consensus estimate.

GoGold Resources (TSE:GGD) said it is advancing construction at its Los Ricos South mine in Mexico after receiving its permit in June, while pursuing a phased development strategy for the larger Los Ricos North project. The company said it remains committed to operating in Mexico despite some indus

One digital asset treasury company is very bullish about Ethereum right now.

Weekends would add 40% more trading hours. Would revenue follow?

Nvidia's close relationship with SK Hynix benefits both companies.

Partially or fully banning diesel exports would backfire in three separate ways.

This company is the backbone of the AI infrastructure trade.

The S&P 500 has continued its march higher.

Contango ORE (NYSEAMERICAN:CTGO) outlined a five-year plan to increase its attributable production from approximately 60,000 ounces of gold to 200,000 ounces of gold and 5 million ounces of silver, with growth expected to come primarily from its Johnson Tract and Kitsault projects. The company said

These two Canadian dividend stocks offer an attractive mix of dividend income and future growth, making both worth a closer look for long-term investors.

Can the rocket and AI giant post a $10.4 billion quarter by the end of 2027?

And it's not the one you're probably thinking of.

Connect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients experiencing acute exacerbations of chronic obstructive pulmonary disease, or COPD. The company said the study met its primary objective, showing reductions in treatment failu

Soon enough, seniors could get more leeway to earn money while collecting benefits.

Unit volumes tell the story of which EV start-up can survive.

IonQ and Alphabet are two completely different investments.

Rafael (NYSE:RFL) reported top-line results from its pivotal Phase III TransportNPC study evaluating Trappsol Cyclo for Niemann-Pick Disease Type C, a rare, progressive genetic disorder. The company said it remains on track to submit a New Drug Application to the U.S. Food and Drug Administration in

Micron's revenue surged 432% over two years while Qualcomm's declined, widening a gap that raises questions about sector dynamics and competitive positioning.

Cameco's stock has fallen from $134 to $85, but that drop could be an opportunity for investors looking to invest in nuclear power.

XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but with a 53% maximum drawdown.

Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH. Chief Executive Officer Andrew Obenshain said the final patient

Nvidia is in command of the AI arms race.

Nokia trades at a steep premium valuation while Verizon generates nearly 13x more net income on a 12.4% margin, a stark contrast in profitability and value.

AI storage needs are accelerating -- and both of these companies are perfectly positioned to benefit.

Howard Hughes (NYSE:HHH) shareholders elected all 11 board nominees, approved the company’s advisory executive-compensation proposal and ratified KPMG as independent auditor for 2026, according to preliminary results announced at the company’s annual meeting. Executive Chair Bill Ackman said each d

The new Federal Reserve chair still has a lot to prove, and political factors are making that harder.

Peoples Bancorp (NASDAQ:PEBO) has agreed to acquire Rockville, Maryland-based Capital Bancorp Inc. in an all-stock transaction valued at approximately $728 million, a deal management described as transformational because it would add scale, national specialty businesses and a more diversified earnin

As investors look for ways to diversify, Bitcoin could soar to new highs.

Both brokers keep drawing in new money. But just one of the two stocks is cheap.

Liberty Silver (OTCMKTS:BHLL) outlined plans to combine Bunker Hill and Silver47, a transaction the company said would create a U.S.-focused, multi-asset mining company centered on silver and other strategic metals. During the presentation, the company said Bunker Hill has entered production at its

The AI build-out isn't slowing down anytime soon.

Alphabet trades at a lower valuation multiple despite slower growth, while Meta invests heavily in hardware amid regulatory headwinds.

Sagimet Biosciences (NASDAQ:SGMT) said its licensed partner Ascletis reported positive 52-week results from an open-label extension study of denifanstat, an oral fatty acid synthase, or FASN, inhibitor being evaluated for moderate-to-severe acne vulgaris in China. The company also outlined plans fo